Global Pricing and Tenders Trends: Navigating EU HTA/JCA, Digital Procurement and ESG
As global pricing and tendering environments continue to evolve, life sciences manufacturers must prepare not only for 2026—but for what comes next.
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
As global pricing and tendering environments continue to evolve, life sciences manufacturers must prepare not only for 2026—but for what comes next.
Advancing EU HTA/JCA milestones, accelerating digital procurement, and rising ESG expectations are fundamentally reshaping how pricing, market access, and tender decisions are made across regions, with long term implications for governance and execution.
In this joint webinar, Model N and Marbls combine strategic insight with real world execution to help organizations navigate today’s disruption while building a foundation for sustained success beyond 2026. Attendees will gain a clear understanding of what’s changing now, what’s coming next, and how leading companies are futureproofing their global pricing and tendering strategies.
You’ll Learn:
The session features a live joint demo, applied industry scenarios, and actionable takeaways designed to help cross functional teams align strategy with execution—and stay competitive in an increasingly complex global pricing and tendering landscape, well beyond 2026.
Sr. Director, Solutions Consulting
Model N
Principal and Chief Commercial Officer, Life Sciences
Marbls
We look forward to having you join us. Please check your inbox for an email with information about the webinar.
Thank you for your interest in Model N. Please submit the form and our sales team will contact you within 24 hours.
We look forward to responding within one business day.